ALR-LRI Collaboration to Accelerate New Lupus Treatments Moving at Fast Pace
The Alliance for Lupus Research (ALR) and the Lupus Research Institute (LRI) are excited to report rapid progress on the cooperative project we launched just months ago to fast-track scientific analysis and identification of potential new treatments for lupus. The lupus community participates with comments, ideas and input on the program’s dedicated LinkedIn site, LRxL STAT.
The proactive initiative focuses on identifying new treatments from among those that are approved for other conditions. We are encouraged that progress has been even more rapid and comprehensive than anticipated with 155 potential therapies analyzed and identified from an initial analysis of 6,800 therapies approved for human use. A prestigious expert committee will soon review these results and prioritize the best candidates for clinical trials in lupus.